000 01657 a2200493 4500
005 20250514005104.0
264 0 _c20011025
008 200110s 0 0 eng d
022 _a0021-9150
024 7 _a10.1016/s0021-9150(01)00418-x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHansen, P R
245 0 0 _aFreunds adjuvant alone is antiatherogenic in apoE-deficient mice and specific immunization against TNFalpha confers no additional benefit.
_h[electronic resource]
260 _bAtherosclerosis
_cSep 2001
300 _a87-94 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntibody Formation
650 0 4 _aAorta
_xpathology
650 0 4 _aApolipoproteins E
_xdeficiency
650 0 4 _aArteriosclerosis
_ximmunology
650 0 4 _aBody Weight
650 0 4 _aChaperonin 60
_ximmunology
650 0 4 _aDisease Susceptibility
650 0 4 _aEnzyme-Linked Immunosorbent Assay
650 0 4 _aFemale
650 0 4 _aFreund's Adjuvant
_ximmunology
650 0 4 _aImmunization
650 0 4 _aLipids
_xblood
650 0 4 _aMalondialdehyde
_ximmunology
650 0 4 _aMice
650 0 4 _aMice, Inbred C57BL
650 0 4 _aRecombinant Proteins
_ximmunology
650 0 4 _aTumor Necrosis Factor-alpha
_ximmunology
700 1 _aChew, M
700 1 _aZhou, J
700 1 _aDaugherty, A
700 1 _aHeegaard, N
700 1 _aJensen, P
700 1 _aMouritsen, S
700 1 _aFalk, E
773 0 _tAtherosclerosis
_gvol. 158
_gno. 1
_gp. 87-94
856 4 0 _uhttps://doi.org/10.1016/s0021-9150(01)00418-x
_zAvailable from publisher's website
999 _c11425398
_d11425398